ATARA BIOTHERAPEUTICS, INC.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $79.2M $48.0M $23.7M $21.9M $51.6M
Accounts Receivable
Inventory
Total Current Assets $172.2M $260.6M $324.6M $106.0M $51.8M
Property, Plant & Equipment $44.1M $3.3M $270.0K $48.0K $8.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $217.8M $263.9M $325.0M $106.1M $51.8M
Liabilities
Accounts Payable $14.7M $2.8M $1.4M $440.0K $606.0K
Total Current Liabilities $27.6M $9.7M $9.7M $2.7M $1.5M
Long-Term Debt
Total Liabilities $39.9M $10.2M $9.9M $2.9M $1.8M
Stockholders' Equity
Retained Earnings $-296.7M $-177.2M $-98.1M $-40.9M $-12.9M
Total Stockholders' Equity $177.9M $253.7M $315.1M $103.2M $-11.0M
← Newer Page 2 of 2 Older →